Jeff Yass’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17M Buy
255,398
+121,523
+91% +$10.3M ﹤0.01% 2650
2026
Q1
$13.3M Buy
+133,875
New +$17.5M ﹤0.01% 2703
2025
Q4
Sell
-90,297
Closed -$11.3M 13624
2025
Q3
$10.1M Buy
90,297
+50,214
+125% +$5.88M ﹤0.01% 3022
2025
Q2
$5.37M Sell
40,083
-50,921
-56% -$5.59M ﹤0.01% 3849
2025
Q1
$6.12M Sell
91,004
-129,600
-59% -$8.91M ﹤0.01% 3276
2024
Q4
$13.8M Buy
220,604
+209,152
+1,826% +$19.5M ﹤0.01% 2265
2024
Q3
$1.8M Buy
+11,452
New +$1.76M ﹤0.01% 5486
2024
Q2
Sell
-110,638
Closed -$13.3M 13237
2024
Q1
$8.18M Buy
110,638
+90,706
+455% +$7.48M ﹤0.01% 2906
2023
Q4
$1.57M Sell
19,932
-32,381
-62% -$1.95M ﹤0.01% 5880
2023
Q3
$2.86M Buy
52,313
+12,377
+31% +$891K ﹤0.01% 4463
2023
Q2
$3.35M Buy
39,936
+27,279
+216% +$2.09M ﹤0.01% 4184
2023
Q1
$959K Buy
+12,657
New +$875K ﹤0.01% 6934
2022
Q4
Sell
-9,678
Closed -$514K 13672
2022
Q3
$404K Sell
9,678
-6,526
-40% -$284K ﹤0.01% 9040
2022
Q2
$510K Buy
16,204
+4,960
+44% +$132K ﹤0.01% 8202
2022
Q1
$303K Buy
+11,244
New +$201K ﹤0.01% 10257
2021
Q3
Sell
-41,156
Closed -$1.26M 13572
2021
Q2
$1.37M Sell
41,156
-48,220
-54% -$1.34M ﹤0.01% 6899
2021
Q1
$3.71M Buy
89,376
+56,807
+174% +$1.75M ﹤0.01% 4505
2020
Q4
$648K Buy
32,569
+15,572
+92% +$230K ﹤0.01% 7718
2020
Q3
$234K Buy
+16,997
New +$291K ﹤0.01% 9202

Other funds holding TMDX

Jeff Yass's TMDX Position: Q2 2026 in Review

Jeff Yass increased its Transmedics (TMDX) stake by 91% in Q2 2026, buying an estimated $10.3M and bringing the position to 255,398 shares worth $17M. The position accounts for ﹤0.01% of the portfolio, ranked #2650.

Jeff Yass first reported a position in TMDX in Q3 2020 and has held it in 19 quarters since. 371 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Jeff Yass held 255,398 shares of Transmedics worth $17M as of Q2 2026.
  • Jeff Yass bought 121,523 Transmedics shares in Q2 2026, an estimated $10.3M.
  • Transmedics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #2650 holding.
  • Jeff Yass first reported a position in Transmedics in Q3 2020 and has held it in 19 quarters since.
  • 371 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.